Position in IBRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$894,761
+$110,887 QoQ
Shares Held
102,200
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#116
of 401 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026REGIONS FINANCIAL CORP holds $27,587,844 across 14 Biotechnology names. IBRX ranks #3 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
34,745 | $21,664,896 | |
| 2 | ARGX |
Argenx SE
|
1,593 | $1,477,937 | |
| 3 | IBRX |
ImmunityBio, Inc.
This page
|
102,200 | $894,761 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,684 | $836,492 | |
| 5 | TECH |
BIO-TECHNE Corp
|
9,781 | $691,027 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,957 | $471,578 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
5,604 | $444,341 | |
| 8 | GMAB |
Genmab A/S
|
15,096 | $414,687 |
All Filings in IBRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $894,761 | 102,200 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $783,874 | 102,200 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $201,960 | 102,000 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $250,920 | 102,000 | Shares | Defined | 2025-11-19 | |
| 2025-06-30 | $269,280 | 102,000 | Shares | Defined | 2025-07-29 | |
| No filing history on record for this holder in this stock. | ||||||